erythropoietin + angiotensin-converting-enzyme inhibitor + angiotensin II receptor blocker

This represents a combination of three distinct types of medical treatments: erythropoietin (a hormone used to stimulate red blood cell production), an ACE inhibitor (a class of drugs that block the conversion of angiotensin I to angiotensin II), and an ARB (a class of drugs that block angiotensin II receptors). While erythropoietin may be used alongside either an ACE inhibitor or an ARB in certain clinical situations, the combination of ACE inhibitors and ARBs together is generally contraindicated due to significant risks of adverse effects, including acute kidney injury, hyperkalemia, and potentially increased cardiovascular mortality. Therefore, this specific triple combination is not recommended in standard clinical practice.

Other names

EPO + ACEI + ARB